Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery
- 1 May 2004
- journal article
- research article
- Published by SAGE Publications in Perfusion
- Vol. 19 (3) , 177-184
- https://doi.org/10.1191/0267659104pf737oa
Abstract
Background: Cardiopulmonary bypass (CPB) evokes a systemic inflammatory response. In attempting to improve the biocompatibility of the equipment, various methods to coat the inner surfaces of the CPB systems have been developed. The present study compares a Trillium Biopassive surface-coated Affinity oxygenator with a Duraflo II totally heparin-coated CPB system. Methods: Low-risk patients admitted for primary coronary artery bypass grafting or aortic valve replacement were randomized to operation using the Trillium- or the Duraflo II-coated setups. Heparin concentration, complement activation (C3bc activation products and terminal complement complex (TCC)), platelet activation (platelet numbers and beta-thromboglobulin (BTG)), leukocyte activation (leukocyte numbers and myeloperoxidase (MPO)), coagulation (thrombin/antithrombin complexes (TAT)) and fibrinolytic activity (plasmin/a2-antiplasmin complexes (PAP)) were measured during CPB and two hours postoperatively. Results: Platelet counts decreased during CPB, without significant intergroup differences. The median BTG concentration increased moderately in both groups and were slightly higher in the Trillium group during CPB (p B-0.05), but not postoperatively. Complement activation products (C3bc and TCC), leukocyte counts, MPO, TAT and PAP activity showed no differences between the two groups. Conclusions: There were small differences in the inflammatory response between the two extracorporeal circulation devices compared in this study.Keywords
This publication has 37 references indexed in Scilit:
- Effect of Trillium™ Biopassive Surface coating of the oxygenator on platelet count drop during cardiopulmonary bypassPerfusion, 1999
- Complement and granulocyte activation in two different types of heparinized extracorporeal circuitsThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coatingThe Annals of Thoracic Surgery, 1995
- Anticoagulant effects of sulphonated polyurethanesBiomaterials, 1992
- COMPLEMENT ACTIVATION AND BIOINCOMPATIBIUTYClinical and Experimental Immunology, 1991
- Synthesis and nonthrombogenicity of polyetherurethaneurea film grafted with poly(sodium vinyl sulfonate)Journal of Biomedical Materials Research, 1991
- Reduced Granulocyte Activation with a Heparin–Coated Device in an In Vitro Model of Cardiopulmonary BypassArtificial Organs, 1991
- Complement activation with bubble and membrane oxygentors in aortocorpnary bypass graftingThe Annals of Thoracic Surgery, 1990
- Detection and Quantification of the Terminal C5b‐9 Complex of Human Complement by a Sensitive Enzyme‐Linked Immunosorbent AssayScandinavian Journal of Immunology, 1984
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983